Waud Capital Partners
Waud Capital Partners is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Waud Capital Partners.
Waud Capital Partners is a company.
Key people at Waud Capital Partners.
Key people at Waud Capital Partners.
Waud Capital Partners is a Chicago-based middle-market private equity firm founded in 1993, specializing in control equity investments in healthcare and software/technology sectors, including their intersections.[2][3][5] Its mission centers on growing world-class companies through a rigorous, process-driven approach that matches high-caliber management teams with attractive sector opportunities, supported by an "Ecosystem" of specialized teams for sourcing, optimization, and scaling.[1][4] The investment philosophy emphasizes proactive research, operational enhancements, and long-term value creation over short-term gains, targeting companies with at least $10 million in revenue, often founder-run with growth potential.[1][2] Key sectors include healthcare (provider services, hospitals, life sciences, non-reimbursement) and technology (e.g., EHR software, workplace platforms), with a track record of 450+ investments across 110+ countries.[3] In the startup and middle-market ecosystem, Waud influences growth by bolstering leadership, optimizing operations, and enabling acquisitions, as seen in exits like selling iOFFICE to Thoma Bravo and partnerships with TeamSnap.[1]
Waud Capital Partners began in 1993 as a one-person, bootstrapped firm in Lake Forest, Illinois, founded by an unnamed individual who made the first investment that year.[3] It raised its debut fund in 1998, relocated to downtown Chicago in 2009, formalized its Ecosystem investment model in 2016, closed its fifth fund in 2018, and marked its 30th anniversary in 2023 with a team of 60+ professionals.[3][6] Key partners include Chris Graber (Healthcare) and Justin DuPere (Software and Technology), backed by a leadership team averaging 25 years of industry experience and 19-year partner tenure, reflecting a culture of trust and growth.[3][6] The firm's evolution shifted from general middle-market focus to healthcare and software/technology, scaling through proprietary research, CEO networks, and operational support to drive sustained expansion.[1][3]
Waud Capital rides trends in healthcare digitization and software/technology intersections, such as EHR systems (e.g., ChiroTouch) and workplace platforms (e.g., iOFFICE, TeamSnap), amid rising demand for scalable tech-enabled services in provider and behavioral health.[1][2][5] Timing aligns with post-pandemic healthcare consolidation and tech adoption, favoring control investments in revenue-stable middle-market firms amid economic pressures on startups.[2][6] Market forces like proprietary research and executive matching position Waud to capitalize on niches, influencing the ecosystem by professionalizing operations, enabling global expansion (110+ countries), and facilitating exits to larger players like Thoma Bravo, thus bridging middle-market growth to broader private equity liquidity.[1][3]
Waud Capital's Ecosystem model and sector focus position it for continued middle-market dominance, with a fund in market since December 2022 likely targeting healthcare-tech synergies amid AI-driven health innovations and software efficiencies.[6] Trends like value-based care, telehealth scaling, and SaaS optimization will shape its trajectory, potentially expanding intersections as aging populations and digital transformation accelerate.[2][5] Its influence may evolve through larger funds, deeper DEI integration (since 2019), and more tech-health hybrids, sustaining the virtuous cycle that started from a single investment in 1993.[3] This disciplined approach ensures Waud remains a growth engine for sector leaders.
